"FDA Adverse Event Reporting System" trang 1 - tải miễn phí từ tailieunhanh
Evaluation of dabigatran and warfarin associated hemorrhagic events using the FDA adverse event reporting system database stratified by age

Evaluation of dabigatran and warfarin associated hemorrhagic events using the FDA adverse event reporting system database stratified by age
10    100    0
Torsades de pointes and QT prolongation associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system

Torsades de pointes and QT prolongation associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system
5    70    0
Báo cáo y học:

Báo cáo y học: "Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations"
5    63    0
Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system

Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system
8    1    1
Rhabdomyolysis associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Rhabdomyolysis associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
6    76    0
Clostridium difficile infection risk with important antibiotic classes: An analysis of the FDA adverse event reporting system

Clostridium difficile infection risk with important antibiotic classes: An analysis of the FDA adverse event reporting system
6    84    0
báo cáo khoa học:

báo cáo khoa học: "Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS"
6    61    0
Báo cáo y học:

Báo cáo y học: "Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AER"
7    41    0
Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection

Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection
10    52    1